Stroke

NeurologyLive spoke with Julie Bernhardt, PhD, to learn more about her investigations into developing guidelines for very early mobilization for stroke treatment.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 14, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 13, 2020.

A net benefit was observed for all functional outcomes across the entire range of the modified Rankin Scale despite an increased risk of symptomatic intracranial hemorrhage.

The professor of neurology at the NYU Langone Grossman School of Medicine outlined the confusion on whether deaths are related to COVID-19, a symptom associated, or previously unidentified underlying condition.

The professor of clinical neurology at University of Miami and MT2020+ chair discussed the initiative’s effort to improve the global accessibility of mechanical thrombectomy.

The EXTEND and EPITHET trials selected patients by perfusion mismatch rather than the less sensitive noncontrast computed tomography, the findings providing reassurance of consistency for thrombolysis-induced reperfusion.

The vascular neurologist at Memorial Hermann Medical Group discusses how stroke care has been affected throughout the COVID-19 pandemic.

The Mission Thrombectomy 2020+ group outlined a plan to increase the awareness, accessibility, and action for mechanical thrombectomy utilization for patients with stroke globally.

An analysis from English and Scottish stroke centers provides physicians a new view of the trends and outcomes of patients with COVID-19 who experience stroke.

Here's what is coming soon to NeurologyLive.

A tertiary analysis of the AVERT study reveals divergent findings suggesting that mortality increases with VEM compared to usual care after restricting follow-up to 14 days.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 6, 2020.

The decision was based on findings from the phase 3 THALES trial, which showed aspirin plus ticagrelor significantly reduced stroke and death compared with aspirin alone in patients with acute ischemic stroke or TIA.

The professor of neurology at the NYU Langone Grossman School of Medicine gave her thoughts on how her recently published data on neurologic disorders in COVID-19 compare to previously reported data.

In addition to recommendations for Alzheimer disease screening, the guidelines also covered stroke risk-related assessments which should be conducted for those with Down syndrome.

Here's what is coming soon to NeurologyLive.

New training pathways are needed to close the gap between capable-physician supply and the growing demand for thrombectomy.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 30, 2020.

The professor of neurology at the NYU Langone Grossman School of Medicine gave her reaction to the data she and colleagues published on neurologic disorders in patients with COVID-19.

The professor of neurology at the NYU Langone Grossman School of Medicine discussed a recent study she and colleagues conducted on new neurological disorders in patients with COVID-19.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 23, 2020.

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.